Public Calendar: December 17 - 23, 2017
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.
Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs
Event Date : 12/20/2017 - 12/20/2017
Location : Silver Spring, MD
Subject : Opioids Epidemic
FDA Participant/Group : KRISTIN DAVIS; ANNA FINE; YOLANDA JENKINS; MAARIKA KIMBRELL; LAUREN SILVIS; ELIZABETH DICKINSON; ANNA ABRAM; KATHLEEN QUINN; THERESA TOIGO;
Non FDA Participant/Group : Justine Handelman; John Cierisanso; Kim Holland (Blue Cross Blue Shield Association (BCBSA);
Official Name : Rachel Sherman, M.D., M.P.H.,, Principal Deputy Commissioner
No Significant Event
Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis
No Significant Event
Official Name : Dara Corrigan, Acting Deputy Commissioner for Global Regulatory Operations and Policy
No Significant Event
Official Name : Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine
No Significant Event
Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs
No Significant Event
Official Name : Jack Kalavritinos, Associate Commissioner for External Affairs
No Significant Event
Official Name : RADM Denise Hinton , Acting Chief Scientist
No Significant Event
Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research
No Significant Event
Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
Event Date : 12/18/2017 - 12/18/2017
Location : Silver Spring, MD
Subject : Medical Imaging and Technology Alliance: Third Party Servicing
FDA Participant/Group : WILLIAM MAISEL; VALERIE FLOURNOY; JOSEPH SHAWKY; LAUREL BURK; DARYLL DYKES; KATELYN BITTLEMAN;
Non FDA Participant/Group : James Nestel; Wayne Moore; Diane Wurzburger; Bob Bove; Cassie Scherer; Donna Haire; Peter Weems (Medical Imaging and Technology Alliance);
Event Date : 12/21/2017 - 12/21/2017
Location : Silver Spring, MD
Subject : Next Generation Sequencing (NGS)
FDA Participant/Group : STAYCE BECK; JOSHUA ST. PIERRE; DONNA ROSCOE; LAURA KOONTZ; REENA PHILIP; EUNICE LEE; ELIZABETH HILLEBRENNER;
Non FDA Participant/Group : Amy Cunniffe (SplitOak Strategies LLC); David Spetzler; Russ Farr; (Caris Life Sciences);
Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition
No Significant Event
Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name : Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name : Rebecca K. Wood, J.D., Chief Counsel
Event Date : 12/19/2017 - 12/19/2017
Location : Silver Spring, Maryland
Subject : Importance of New Medication Assisted Treatments(MATS) for Public Health–Legal Issues
FDA Participant/Group : JENNIFER SCHWARTZ; GIOIA GUERRIERI; ELIZABETH DICKINSON; DOUGLAS THROCKMORTON; COLLEEN KELLY; NISHA SHAH; GRAIL SIPES; CELIA WINCHELL; PETER STEIN; NANCY BOOCKER; SHARON HERTZ; KAREN SCHIFTER;
Non FDA Participant/Group : Scott Lassman (Goodwin Procter LLP); David McIntyre , Genie Bailey , Joshua Sherman, Mike Derkacz , Paul Varki , Sonnie Kim (Braeburn Pharmaceuticals Incorporated); Lisa Dwyer, Sheldon Bradshaw (King & Spalding LLP);